By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Medivir AB 

Lunastigen 7

Huddinge    141 44  Sweden
Phone: 46-8-608-3100 Fax: 46-8-608-3199


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

GlaxoSmithKline (North Carolina) 

Peptimmune, Inc.  Development agreement for inhibitors of Cathepsin S for autoimmune and allergic diseases.





Company News
Medivir (MVRBF) – Interim Report, January – June 2016 8/17/2016 11:25:01 AM
Medivir (MVRBF) Licenses Rights To MIV-802 To Trek Therapeutics 8/17/2016 9:59:17 AM
Medivir (MVRBF): New Interim Phase IIa Data On Simeprevir In Combination With Other Daas Will Be Presented At The Upcoming EASL AASLD Special Conference 8/11/2016 11:55:12 AM
Medivir (MVRBF) Mulls Over Possible Corporate Split and Separate Listing of Commercial Operations 6/15/2016 6:00:24 AM
Medivir (MVRBF) Announces That Janssen R&D Decided To Start A Phase IIb Study Of Combinations Of Simeprevir, Odalasvir And AL-335 For The Treatment Of Hepatitis C 5/11/2016 11:00:59 AM
Resolutions At The Annual General Meeting In Medivir (MVRBF) On 3 May 2016 5/3/2016 10:50:34 AM
Medivir (MVRBF) – Interim Report, January – March 2016 4/28/2016 12:08:31 PM
Medivir (MVRBF): OLYSIO Sales During The First Quarter 2016 4/19/2016 12:15:48 PM
Medivir (MVRBF): New Data For Simeprevir Will Be Presented At Easl's International Liver Congress 2016 4/11/2016 9:20:20 AM
Medivir (MVRBF): Annual Report 2015 4/6/2016 10:34:03 AM
12345678910...
//-->